Trends in prostate needle biopsy diagnosis. A ten year experience of a medical center in Taiwan

Pathology International

Volumn 62, Issue 3, 2012, Pages 191-198

  Kuo, Ying Ju ^a   Lin, Shiou Fu ^a   Chang, Yen Hwa ^a   Pan, Chin Chen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Gleason score; High grade prostatic intraepithelial neoplasia; Needle biopsy; Prostate adenocarcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; GENERAL HOSPITAL; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE NEEDLE BIOPSY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TAIWAN; TREND STUDY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TAIWAN;

EID: 84862820100     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02794.x     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Gu FL, Xia TL, Kong XT. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China. Urology 1994; 44: 688-91.
3. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85: 60-7.
4. Chia SE, Tan CS, Lim GH, Sim X, Lau W, Chia KS. Incidence, mortality and five-year relative survival ratio of prostate cancer among Chinese residents in Singapore from 1968 to 2002 by metastatic staging. Ann Acad Med Singapore 2010; 39: 466-71.
5. Pu YS. Prostate cancer in Taiwan: Epidemiology and risk factors. Int J Androl 2000; 23 Suppl 2: 34-6.
6. Pu YS, Chiang HS, Lin CC, Huang CY, Huang KH, Chen J. Changing trends of prostate cancer in Asia. Aging Male 2004; 7: 120-32.
7. Sim HG, Cheng CW. Changing demography of prostate cancer in Asia. Eur J Cancer 2005; 41: 834-45.
8. Wu TT, Huang JK. Annual changes in the clinical features of prostatic adenocarcinoma in Taiwan. BJU Int 2001; 87: 57-60.
9. Bureau of Health Promotion. 2008 Cancer registry annual report 1987-2007. Bureau of Health Promotion, Department of Health, Republic of China (Taiwan).
10. Pan CC, Potter SR, Partin AW, Epstein JI. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: A proposal to modify the Gleason grading system. Am J Surg Pathol 2000; 24: 563-9.
11. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-42.
12. Netto GJ, Epstein JI. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: A significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol 2006; 30: 1184-8.
13. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
14. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: A systematic review. J Urol 2006; 175: 1605-12.
15. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199-202.
16. Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon-Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 2000; 164: 393-6.
17. Sung JF, Lin RS, Pu YS, Chen YC, Chang HC, Lai MK. Risk factors for prostate carcinoma in Taiwan: A case-control study in a Chinese population. Cancer 1999; 86: 484-91.
18. Bismar TA, Lewis JS Jr, Vollmer RT, Humphrey PA. Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population. Am J Surg Pathol 2003; 27: 432-40.
19. Bishara T, Ramnani DM, Epstein JI. High-grade prostatic intraepithelial neoplasia on needle biopsy: Risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern. Am J Surg Pathol 2004; 28: 629-33.
20. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: Implications for patient care. J Urol 2006; 175: 820-34.
21. Kobayashi T, Nishizawa K, Watanabe J, Ogura K, Mitsumori K, Ide Y. Effects of sextant transrectal prostate biopsy plus additional far lateral cores in improving cancer detection rates in men with large prostate glands. Int J Urol 2004; 11: 392-6.
22. O'dowd GJ, Miller MC, Orozco R, Veltri RW. Analysis of repeated biopsy results within 1year after a noncancer diagnosis. Urology 2000; 55: 553-9.
23. Weinstein MH, Greenspan DL, Epstein JI. Diagnoses rendered on prostate needle biopsy in community hospitals. Prostate 1998; 35: 50-5.
24. Tan PH, Tan HW, Tan Y, Lim CN, Cheng C, Epstein JI. Is high-grade prostatic intraepithelial neoplasia on needle biopsy different in an Asian population: A clinicopathologic study performed in Singapore. Urology 2006; 68: 800-3.
25. Kronz JD, Allan CH, Shaikh AA, Epstein JI. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: Data on men with more than one follow-up biopsy. Am J Surg Pathol 2001; 25: 1079-85.